For: | Lee T, Teng TZJ, Shelat VG. Carbohydrate antigen 19-9 — tumor marker: Past, present, and future. World J Gastrointest Surg 2020; 12(12): 468-490 [PMID: 33437400 DOI: 10.4240/wjgs.v12.i12.468] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v12/i12/468.htm |
Number | Citing Articles |
1 |
Yizhen Zhang, Qingwei Jiang, Qiang Wang, Yunlu Feng, Dongsheng Wu, Tao Guo, Shengyu Zhang, Xi Chen, Yingyun Yang, Wen Shi, Xi Wu, Aiming Yang. Predicting Malignancy of Biliary Stricture with a Nomogram in Patients with a Non-Malignant Endoscopic Tissue Diagnosis: A Retrospective Study. Cancer Management and Research 2021; : 7735 doi: 10.2147/CMAR.S333333
|
2 |
Hiroki Morikawa, Takaaki Oba, Ayaka Kitazawa, Ryoko Iji, Nami Kiyosawa, Masatsugu Amitani, Tadafumi Shimizu, Toshiharu Kanai, Takeshi Uehara, Ken-ichi Ito. CA19-9 producing locally advanced papillary thyroid carcinoma: a case report. Surgical Case Reports 2024; 10(1) doi: 10.1186/s40792-024-01887-w
|
3 |
Shigemasa Takamizawa, Tatsunori Shimoi, Masayuki Yoshida, Momoko Tokura, Shu Yazaki, Chiharu Mizoguchi, Ayumi Saito, Shosuke Kita, Kasumi Yamamoto, Yuki Kojima, Hitomi Sumiyoshi-Okuma, Tadaaki Nishikawa, Emi Noguchi, Kazuki Sudo, Kan Yonemori. Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09514-3
|
4 |
Abd AlRahman Mohammad Foda, Tarek Atia, Hader I. Sakr, Khaled Abd Elaziz Ahmed Elnaghi, Wagih M. Abdelhay, Eman T. Enan. Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression. Journal of Evidence-Based Integrative Medicine 2023; 28 doi: 10.1177/2515690X231198315
|
5 |
Joao Victor Machado Carvalho, Valérie Dutoit, Claudia Corrò, Thibaud Koessler. Promises and Challenges of Predictive Blood Biomarkers for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. Cells 2023; 12(3): 413 doi: 10.3390/cells12030413
|
6 |
Mark Bates, Bashir M. Mohamed, Faye Lewis, Sharon O’Toole, John J. O’Leary. Biomarkers in high grade serous ovarian cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; : 189224 doi: 10.1016/j.bbcan.2024.189224
|
7 |
Ryan Munnings, Peter Gibbs, Belinda Lee. Evolution of Liquid Biopsies for Detecting Pancreatic Cancer. Cancers 2024; 16(19): 3335 doi: 10.3390/cancers16193335
|
8 |
Alexandra-Simona Zamfir, Mihai Lucian Zabara, Raluca Ioana Arcana, Tudor Andrei Cernomaz, Andreea Zabara-Antal, Marius Traian Dragoș Marcu, Antigona Trofor, Carmen Lăcrămioara Zamfir, Radu Crișan-Dabija. Exploring the Role of Biomarkers Associated with Alveolar Damage and Dysfunction in Idiopathic Pulmonary Fibrosis—A Systematic Review. Journal of Personalized Medicine 2023; 13(11): 1607 doi: 10.3390/jpm13111607
|
9 |
Keren Shen, Weixing Mo, Xiaojie Wang, Dan Shi, Wei Qian, Jihong Sun, Risheng Yu. A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features. European Radiology 2023; 33(12): 8986 doi: 10.1007/s00330-023-09873-w
|
10 |
·阿曼交尔 热哈提. Association of CA19-9 with Prognosis of Non-Small Cell Lung Cancer. Advances in Clinical Medicine 2024; 14(01): 585 doi: 10.12677/ACM.2024.141081
|
11 |
Nebojsa Manojlovic, Goran Savic, Bojan Nikolic, Nemanja Rancic. Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapy. World Journal of Clinical Cases 2022; 10(3): 899-918 doi: 10.12998/wjcc.v10.i3.899
|
12 |
Sonia Perales, Carolina Torres, Cristina Jimenez-Luna, Jose Prados, Joaquina Martinez-Galan, Jose Manuel Sanchez-Manas, Octavio Caba. Liquid biopsy approach to pancreatic cancer. World Journal of Gastrointestinal Oncology 2021; 13(10): 1263-1287 doi: 10.4251/wjgo.v13.i10.1263
|
13 |
Christina Jane Vellan, Jaime Jacqueline Jayapalan, Boon-Koon Yoong, Azlina Abdul-Aziz, Sarni Mat-Junit, Perumal Subramanian. Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review. International Journal of Molecular Sciences 2022; 23(4): 2093 doi: 10.3390/ijms23042093
|
14 |
Athar Nakisa, Lorenzo F. Sempere, Xi Chen, Linda T. Qu, Daniel Woldring, Howard C. Crawford, Xuefei Huang. Tumor‐Associated Carbohydrate Antigen 19–9 (CA 19–9), a Promising Target for Antibody‐Based Detection, Diagnosis, and Immunotherapy of Cancer. ChemMedChem 2024; doi: 10.1002/cmdc.202400491
|
15 |
Purva Gopal, Marie E. Robert, Xuchen Zhang. Cholangiocarcinoma: Pathologic and Molecular Classification in the Era of Precision Medicine. Archives of Pathology & Laboratory Medicine 2024; 148(3): 359 doi: 10.5858/arpa.2022-0537-RA
|
16 |
Andrea Pinkeova, Natalia Kosutova, Eduard Jane, Lenka Lorencova, Aniko Bertokova, Tomas Bertok, Jan Tkac. Medical Relevance, State-of-the-Art and Perspectives of “Sweet Metacode” in Liquid Biopsy Approaches. Diagnostics 2024; 14(7): 713 doi: 10.3390/diagnostics14070713
|
17 |
Filbert H. Juwono, W.K. Wong, Hui Ting Pek, Saaveethya Sivakumar, Donata D. Acula. Ovarian cancer detection using optimized machine learning models with adaptive differential evolution. Biomedical Signal Processing and Control 2022; 77: 103785 doi: 10.1016/j.bspc.2022.103785
|
18 |
Zhenghong Le, Shuran Chen, Yan Feng, Weichen Lu, Mulin Liu. SERPINC1, a new prognostic predictor of colon cancer, promote colon cancer progression through EMT. Cancer Reports 2024; 7(6) doi: 10.1002/cnr2.2079
|
19 |
Mridula Bhadra, Manisha Sachan, Seema Nara. Current strategies for early epithelial ovarian cancer detection using miRNA as a potential tool. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1361601
|
20 |
Safia Samir, Mohamed El-Ashry, Waleed Soliman, Marwa Hassan. Urinary biomarkers analysis as a diagnostic tool for early detection of pancreatic adenocarcinoma: Molecular quantification approach. Computational Biology and Chemistry 2024; 112: 108171 doi: 10.1016/j.compbiolchem.2024.108171
|
21 |
Ze-mao Li, Wei Zhou, Li Feng, Hui-ying Zhang, Wei-bin Chen. Predictive value of preoperative CT enhancement rate and CT perfusion parameters in colorectal cancer. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03257-0
|
22 |
Pratibha Malhotra, Ranjith Palanisamy, Jose A. Caparros-Martin, Marco Falasca. Bile Acids and Microbiota Interplay in Pancreatic Cancer. Cancers 2023; 15(14): 3573 doi: 10.3390/cancers15143573
|
23 |
Zaki H Hakami. Biomarker discovery and validation for gastrointestinal tumors: A comprehensive review of colorectal, gastric, and liver cancers. Pathology - Research and Practice 2024; 255: 155216 doi: 10.1016/j.prp.2024.155216
|
24 |
Thomas Zheng Jie Teng, Branden Qi Yu Chua, Vishal G Shelat. Carcinosarcoma of gallbladder: A world review. World Journal of Clinical Oncology 2021; 12(12): 1244-1263 doi: 10.5306/wjco.v12.i12.1244
|
25 |
Andrey D. Dolbnya, Igor A. Popov, Stanislav I. Pekov. Molecular Biomarkers in Cholangiocarcinoma: Focus on Bile. Current Topics in Medicinal Chemistry 2024; 24(8): 722 doi: 10.2174/0115680266290367240130054142
|
26 |
Ryan J Kramer, Chanjuan Shi, Dimitrios Moris, Peter J Allen. Benign Etiology for High-Risk Intraductal Papillary Mucinous Neoplasm: A Case Report and Literature Review. Cureus 2024; doi: 10.7759/cureus.62054
|
27 |
Jihyun Keum, Won Moo Lee, Joong Sub Choi, Jaeman Bae, Seongsil Cho, Bo Kyeong Kang. Diagnostic Clues for Women with Acute Surgical Abdomen Associated with Ruptured Endometrioma. Journal of Personalized Medicine 2023; 13(8): 1226 doi: 10.3390/jpm13081226
|
28 |
A.F. van Oosten, V.P. Groot, G. Dorland, Richard A. Burkhart, C.L. Wolfgang, H.C. van Santvoort, J. He, I.Q Molenaar, L.A. Daamen. Dynamics of Serum CA19-9 in Patients Undergoing Pancreatic Cancer Resection. Annals of Surgery 2023; doi: 10.1097/SLA.0000000000005977
|
29 |
Mohamed Badheeb, Adham Abdelrahim, Abdullah Esmail, Godsfavour Umoru, Karen Abboud, Ebtesam Al-Najjar, Ghaith Rasheed, Mohammed Alkhulaifawi, Ala Abudayyeh, Maen Abdelrahim. Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening. Current Oncology 2022; 29(11): 8693 doi: 10.3390/curroncol29110686
|
30 |
Arturo Orlacchio, Stephen Muzyka, Tamas A. Gonda. Epigenetic Regulation of Cancer - Part B. International Review of Cell and Molecular Biology 2024; 383: 1 doi: 10.1016/bs.ircmb.2023.10.002
|
31 |
Rishaan Pawaskar, Kevin Zhang Huang, Helen Pham, Adnan Nagrial, Mark Wong, Siobhan O’Neill, Henry Pleass, Lawrence Yuen, Vincent W. T. Lam, Arthur Richardson, Tony Pang, Christopher B. Nahm. Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma. Cancers 2024; 16(4): 698 doi: 10.3390/cancers16040698
|
32 |
Sebastian Blaj, David Dora, Zoltan Lohinai, Zoltan Herold, Attila Marcell Szasz, Jonas Herzberg, Roland Kodacsi, Saher Baransi, Hans Jürgen Schlitt, Matthias Hornung, Jens M. Werner, Przemyslaw Slowik, Miklos Acs, Pompiliu Piso. Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers. Cancers 2023; 15(4): 1326 doi: 10.3390/cancers15041326
|
33 |
Violetta Rosiek, Agnes Bocian-Jastrzębska, Beata Kos-Kudła. Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome. Cancers 2023; 15(8): 2348 doi: 10.3390/cancers15082348
|
34 |
Ryuichiro Sato, Masaya Oikawa, Tetsuya Kakita, Tomoya Abe, Naoya Akazawa, Haruka Okano, Kei Ito, Takashi Tsuchiya. Prognostic value of carcinoembryonic antigen (CEA) and CA 19-9 levels in patients with obstructive colorectal cancer treated with a self-expandable metallic stent and curative surgery. Surgery Today 2024; doi: 10.1007/s00595-024-02943-6
|
35 |
Yuichiro Onuki, Hirochika Matsubara, Ryunosuke Koizumi, Mamoru Muto, Harunobu Sasanuma, Daisuke Sato, Aya Sugimura, Tsuyoshi Uchida, Hiroyasu Matsuoka, Hiroyuki Nakajima. Prognostic evaluation of preoperative serum tumor marker‐negative cases in non‐small cell lung cancer: A retrospective study. Cancer Reports 2023; 6(2) doi: 10.1002/cnr2.1696
|
36 |
Jakub Ciesielka, Krzysztof Jakimów, Natalia Tekiela, Laura Peisert, Anna Kwaśniewska, Dariusz Kata, Jerzy Chudek. Significantly Elevated CA 19-9 after COVID-19 Vaccination and Literature Review of Non-Cancerous Cases with CA 19-9 > 1000 U/mL. Journal of Clinical Medicine 2024; 13(5): 1263 doi: 10.3390/jcm13051263
|
37 |
Matthew R Kudelka, Wei Gu, Yasuyuki Matsumoto, Tongzhong Ju, Richard H Barnes II, Robert J Kardish, Jamie Heimburg-Molinaro, Sylvain Lehoux, Junwei Zeng, Cynthia Cohen, Brian S Robinson, Kinjal S Shah, Elliot L Chaikof, Sean R Stowell, Richard D Cummings. Targeting altered glycosylation in secreted tumor glycoproteins for broad cancer detection. Glycobiology 2023; 33(7): 567 doi: 10.1093/glycob/cwad035
|
38 |
Kenichiro Okumura, Kazuto Kozaka, Azusa Kitao, Norihide Yoneda, Takahiro Ogi, Hiroko Ikeda, Toshifumi Gabata, Satoshi Kobayashi. Imaged periductal infiltration: Diagnostic and prognostic role in intrahepatic mass-forming cholangiocarcinoma. European Journal of Radiology Open 2024; 12: 100554 doi: 10.1016/j.ejro.2024.100554
|
39 |
Marlies Maly, Lieve Vanwalleghem, Anja Van Den Eeckhaut, Vincent De Wilde. Cancer of unknown primary and BRAF V600E meeting the BEACON combination: A case report. Molecular and Clinical Oncology 2024; 21(6) doi: 10.3892/mco.2024.2786
|
40 |
Ingrid Garajová, Marianna Peroni, Fabio Gelsomino, Francesco Leonardi. A Simple Overview of Pancreatic Cancer Treatment for Clinical Oncologists. Current Oncology 2023; 30(11): 9587 doi: 10.3390/curroncol30110694
|
41 |
Violetta Rosiek, Ksenia Janas, Magdalena Witkowska, Beata Kos-Kudła. Role of Selected Circulating Tumor Biomarkers in Patients with Skeletal Metastatic Pancreatic Neuroendocrine Neoplasms. Journal of Clinical Medicine 2023; 12(14): 4687 doi: 10.3390/jcm12144687
|
42 |
Austin D. Silva, Jihye Hwang, Michael P. Marciel, Susan L. Bellis. The pro-inflammatory cytokines IL-1β and IL-6 promote upregulation of the ST6GAL1 sialyltransferase in pancreatic cancer cells. Journal of Biological Chemistry 2024; 300(10): 107752 doi: 10.1016/j.jbc.2024.107752
|
43 |
P. M. Sokolov, P. S. Samokhvalov, D. A. Baranova, A. V. Sukhanova. Principles and approaches in the development of fluorescent hydrogels for cancer diagnosis. Russian Journal of Biotherapy 2023; 22(4): 17 doi: 10.17650/1726-9784-2023-22-4-17-27
|
44 |
Xiaolei Zhou. Meta-analysis of the diagnostic performance of serum carbohydrate antigen 19-9 for the detection of gallbladder cancer. The International Journal of Biological Markers 2022; 37(1): 81 doi: 10.1177/17246008211068866
|
45 |
Muhammad Ghallab, Hazem Abosheaishaa, Ishank Gupta, Salma Abdelmoteleb, Roger Stern. A Case of Choledocholithiasis and Obstructive Jaundice With a Very High Serum Carbohydrate Antigen 19-9 (CA 19-9) Level: A Case Report and Review of Literature. Cureus 2022; doi: 10.7759/cureus.32447
|
46 |
Kendelle J. Murphy, Cecilia R. Chambers, David Herrmann, Paul Timpson, Brooke A. Pereira. Dynamic Stromal Alterations Influence Tumor-Stroma Crosstalk to Promote Pancreatic Cancer and Treatment Resistance. Cancers 2021; 13(14): 3481 doi: 10.3390/cancers13143481
|
47 |
Bernard Jonathan Christian Yong, Made Wirama Diyana. Low Carbohydrate Antigen 19-9 (CA 19-9) Levels in a Patient Highly Suspected of Having Caput Pancreas Tumor. Cureus 2022; doi: 10.7759/cureus.24357
|
48 |
Sara Ansari, Parvaneh Nikpour. Identification of Cancer/Testis Antigens Related to Gastric Cancer Prognosis Based on Co-Expression Network and Integrated Transcriptome Analyses. Advanced Biomedical Research 2023; 12(1) doi: 10.4103/abr.abr_400_21
|
49 |
S. Tan, M. Machrumnizar. Fish and Food-Fatale: Food-borne Trematode Opisthorchis viverrini and Cholangiocarcinoma. Helminthologia 2023; 60(4): 287 doi: 10.2478/helm-2023-0036
|
50 |
Aditya V. Shreenivas, Shumei Kato, Jingjing Hu, Catherine Skefos, Jason Sicklick, Razelle Kurzrock. Carcinoma of unknown primary: Molecular tumor board‐based therapy. CA: A Cancer Journal for Clinicians 2022; 72(6): 510 doi: 10.3322/caac.21748
|
51 |
Kim-Lea Reese, Klaus Pantel, Daniel J. Smit. Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer – a comprehensive review. Journal of Experimental & Clinical Cancer Research 2024; 43(1) doi: 10.1186/s13046-024-03166-w
|
52 |
Jonathan G. A. Koo, Hui Yu Tham, En Qi Toh, Christopher Chia, Amy Thien, Vishal G. Shelat. Mirizzi Syndrome—The Past, Present, and Future. Medicina 2023; 60(1): 12 doi: 10.3390/medicina60010012
|
53 |
Rui Chen, Zhengli Zhou, Qihua Dang, Changjing Zuo, Tao Wang. High expression of Testin predicted worse prognosis in pancreatic adenocarcinoma associated with immune infiltration. Molecular & Cellular Toxicology 2024; doi: 10.1007/s13273-024-00448-4
|
54 |
Jaume Trapé, Esther Fernández-Galán, Josep Maria Auge, Marina Carbonell-Prat, Xavier Filella, Sílvia Miró-Cañís, Carolina González-Fernández, Stefan Holdenrieder, Huub van Rossum, Michel van den Heuvel. Factors influencing blood tumor marker concentrations in the absence of neoplasia. Tumor Biology 2024; 46(s1): S35 doi: 10.3233/TUB-220023
|
55 |
Giampaolo Perri, Santhi Swaroop Vege, Giovanni Marchegiani. Monitoring Ca19‐9 during pancreatic cyst surveillance: Better safe than sorry?. United European Gastroenterology Journal 2023; 11(7): 599 doi: 10.1002/ueg2.12449
|
56 |
Bryson W. Katona, Christine Worthington, Daniel Clay, Hannah Cincotta, Nuzhat A. Ahmad, Gregory G. Ginsberg, Michael L. Kochman, Randall E. Brand. Outcomes of the IMMray PanCan-d Test in High-Risk Individuals Undergoing Pancreatic Surveillance: Pragmatic Data and Lessons Learned. JCO Precision Oncology 2023; (7) doi: 10.1200/PO.23.00445
|
57 |
Ji Ha Lim, Jung Wook Huh, Woo Yong Lee, Seong Hyeon Yun, Hee Cheol Kim, Yong Beom Cho, Yoon Ah Park, Jung Kyong Shin. Comparison of Long-Term Survival Outcomes of T4a and T4b Colorectal Cancer. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.780684
|
58 |
Luis Secanella, Juli Busquets, Núria Peláez, María Sorribas, Berta Laquente, Sandra Ruiz-Osuna, Juan Fabregat. The involvement of the hepatic artery is a risk factor for unresectability after neoadjuvant treatment in borderline pancreatic adenocarcinoma. Surgical Oncology 2024; 52: 102027 doi: 10.1016/j.suronc.2023.102027
|
59 |
Jagannath Mondal, Jeong Man An, Sachin S. Surwase, Kushal Chakraborty, Sabuj Chandra Sutradhar, Joon Hwang, Jaewook Lee, Yong-Kyu Lee. Carbon Nanotube and Its Derived Nanomaterials Based High Performance Biosensing Platform. Biosensors 2022; 12(9): 731 doi: 10.3390/bios12090731
|
60 |
Daniel Keefe, Rasheid Smith, Bingtao Gao, Walla I. Malkawi, Sean M. Geary, Pashtoon M. Kasi, Saima Sharif, Aliasger K. Salem, Fatima Toor. Colorectal Cancer Biosensor Using Vertically-Oriented Silicon Nanowires. 2022 IEEE Sensors 2022; : 1 doi: 10.1109/SENSORS52175.2022.9967069
|
61 |
Di Wang, Katarina Madunić, Oleg A. Mayboroda, Guinevere S.M. Lageveen-Kammeijer, Manfred Wuhrer. (Sialyl)Lewis Antigen Expression on Glycosphingolipids, N-, and O-Glycans in Colorectal Cancer Cell Lines is Linked to a Colon-Like Differentiation Program. Molecular & Cellular Proteomics 2024; 23(6): 100776 doi: 10.1016/j.mcpro.2024.100776
|
62 |
Niloofar Asadi Hanjani, Nazanin Esmaelizad, Saba Zanganeh, Abdulwahab Teflischi Gharavi, Pegah Heidarizadeh, Maryam Radfar, Fateme Omidi, Ronan MacLoughlin, Mohammad Doroudian. Emerging role of exosomes as biomarkers in cancer treatment and diagnosis. Critical Reviews in Oncology/Hematology 2022; 169: 103565 doi: 10.1016/j.critrevonc.2021.103565
|
63 |
Jacek Baj, Łukasz Bryliński, Filip Woliński, Michał Granat, Katarzyna Kostelecka, Piotr Duda, Jolanta Flieger, Grzegorz Teresiński, Grzegorz Buszewicz, Marzena Furtak-Niczyporuk, Piero Portincasa. Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know. Cancers 2022; 14(6): 1493 doi: 10.3390/cancers14061493
|
64 |
Shuuji Mawaribuchi, Osamu Shimomura, Tatsuya Oda, Keiko Hiemori, Kayoko Shimizu, Kenya Yamase, Mutsuhiro Date, Hiroaki Tateno. rBC2LCN-reactive SERPINA3 is a glycobiomarker candidate for pancreatic ductal adenocarcinoma. Glycobiology 2023; 33(4): 342 doi: 10.1093/glycob/cwad009
|
65 |
Beatriz A. Gonzales, Alessandro L. Diniz, Silvio M. Torres, Héber Salvador de Castro Ribeiro, Igor Correia de Farias, André Luís de Godoy, Felipe J. F. Coimbra, Victor H. Fonseca de Jesus. Patterns of disease relapse and posttreatment follow‐up of patients with resected pancreatic adenocarcinoma: A single‐center analysis. Journal of Surgical Oncology 2022; 126(4): 708 doi: 10.1002/jso.26985
|
66 |
Sima Kalantari, Akram Pourshams, Raheleh Roudi, Hakimeh Zali, Mojgan Bandehpour, Abolfazl Kalantari, Reza Ghanbari, Alberto D'Angelo, Bahram Kazemi, Zahra Madjd. Identification of Potential Common Molecular Factors of Pancreatic Cancer and Diabetes Mellitus using Microarray Data Analysis Combined with Bioinformatics Techniques and Experimental Validation. Biomedical and Biotechnology Research Journal (BBRJ) 2021; 5(3): 286 doi: 10.4103/bbrj.bbrj_122_21
|
67 |
Peng Ge, Yalan Luo, Haiyang Chen, Jiayue Liu, Haoya Guo, Caiming Xu, Jialin Qu, Guixin Zhang, Hailong Chen. Application of Mass Spectrometry in Pancreatic Cancer Translational Research. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.667427
|
68 |
Valentina Giansante, Gianmarco Stati, Silvia Sancilio, Emanuela Guerra, Saverio Alberti, Roberta Di Pietro. The Dual Role of Necroptosis in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2023; 24(16): 12633 doi: 10.3390/ijms241612633
|
69 |
Guolin Yin, Miaomiao Zhang, Bing Zhao, Zaixing Yang. High serum levels of CA 19-9 and CYFRA21-1 caused by renal pelvis urothelial carcinoma: a report of two cases. Journal of International Medical Research 2021; 49(3) doi: 10.1177/03000605211002692
|
70 |
Amy Makler, Waseem Asghar. Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study. International Journal of Molecular Sciences 2023; 24(6): 5081 doi: 10.3390/ijms24065081
|
71 |
Fahmy T. Ali, Reham M. Soliman, Nahla S. Hassan, Ahmed M. Ibrahim, Mayada M. El-Gizawy, Abd Allah Y. Mandoh, Ehab A. Ibrahim, Elizabeth Christie. Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer. PLOS ONE 2022; 17(8): e0272308 doi: 10.1371/journal.pone.0272308
|
72 |
Biaoming Xu, Yu Chen, Mingjing Peng, Jin Hai Zheng, Chaohui Zuo. Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma. International Journal of Cancer 2023; 152(2): 110 doi: 10.1002/ijc.34195
|
73 |
Brian M. Fung, James H. Tabibian. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices. Expert Review of Gastroenterology & Hepatology 2021; 15(5): 487 doi: 10.1080/17474124.2021.1900732
|
74 |
Valeria Tonini, Manuel Zanni. Early diagnosis of pancreatic cancer: What strategies to avoid a foretold catastrophe. World Journal of Gastroenterology 2022; 28(31): 4235-4248 doi: 10.3748/wjg.v28.i31.4235
|
75 |
Rohit Pujari, Shiv Kumar Dubey. Relevance of glyco-biomakers and glycan profiles in cancer stem cells. Glycobiology 2024; 34(6) doi: 10.1093/glycob/cwad019
|
76 |
Taisuke Imamura, Katsuhisa Ohgi, Yukiyasu Okamura, Teiichi Sugiura, Takaaki Ito, Yusuke Yamamoto, Ryo Ashida, Shimpei Otsuka, Shunsuke Tamura, Katsuhiko Uesaka. The clinical benefits of performing staging laparoscopy for pancreatic cancer treatment. Pancreatology 2022; 22(5): 636 doi: 10.1016/j.pan.2022.03.017
|
77 |
Ashlyn McConnell, Tyler Stoneman, Stanley Hewlett. Extraordinarily high serum CA 19-9 in setting of pancreatic necrosis and underlying pancreatic adenocarcinoma: a case report. Journal of Surgical Case Reports 2023; 2023(10) doi: 10.1093/jscr/rjad550
|
78 |
Yuki Shimizu, Shintaro Kanda, Toshirou Fukushima, Takashi Kobayashi, Ryoichi Kondo, Tomonobu Koizumi. Increased carbohydrate antigen 19‐9 expression in a thymic neuroendocrine tumor. Thoracic Cancer 2021; 12(21): 2949 doi: 10.1111/1759-7714.14153
|
79 |
Aleksander M. Bogdanski, Jeanin E. van Hooft, Bas Boekestijn, Bert A. Bonsing, Martin N. J. M. Wasser, Derk C. F. Klatte, Monique E. van Leerdam. Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. Familial Cancer 2024; 23(3): 323 doi: 10.1007/s10689-024-00368-1
|
80 |
So Jeong Yoon, Seung Soo Hong, Kee-Taek Jang, So Kyung Yoon, Hongbeom Kim, Sang Hyun Shin, Jin Seok Heo, Chang Moo Kang, Kyung Sik Kim, Ho Kyoung Hwang, In Woong Han. Predicting lymph node metastasis using preoperative parameters in patients with T1 ampulla of vater cancer. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12311-9
|
81 |
Jacob E. Till, Lee McDaniel, Changgee Chang, Qi Long, Shannon M. Pfeiffer, Jaclyn P. Lyman, Lacey J. Padrón, Deena M. Maurer, Jia Xin Yu, Christine N. Spencer, Pier Federico Gherardini, Diane M. Da Silva, Theresa M. LaVallee, Charles Abbott, Richard O. Chen, Sean M. Boyle, Neha Bhagwat, Samuele Cannas, Hersh Sagreiya, Wenrui Li, Stephanie S. Yee, Aseel Abdalla, Zhuoyang Wang, Melinda Yin, Dominique Ballinger, Paul Wissel, Jennifer Eads, Thomas Karasic, Charles Schneider, Peter O’Dwyer, Ursina Teitelbaum, Kim A. Reiss, Osama E. Rahma, George A. Fisher, Andrew H. Ko, Zev A. Wainberg, Robert A. Wolff, Eileen M. O’Reilly, Mark H. O’Hara, Christopher R. Cabanski, Robert H. Vonderheide, Erica L. Carpenter. Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-49915-5
|
82 |
Phyllis A. Gimotty, Jacob E. Till, Shirsa Udgata, Naomi Takenaka, Stephanie S. Yee, Michael J. LaRiviere, Mark H. O’Hara, Kim A. Reiss, Peter O'Dwyer, Bryson W. Katona, Daniel Herman, Erica L. Carpenter, Kenneth S. Zaret. THSB2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma. Oncotarget 2021; 12(22): 2266 doi: 10.18632/oncotarget.28099
|
83 |
Yuanyuan Jiang, Shichao Duan, Jiaming Li, Yanli Zhao, Jinsong Yang. Chemical and chemoenzymatic syntheses of sialyl Lewisa tetrasaccharide antigen. Organic & Biomolecular Chemistry 2024; 22(28): 5776 doi: 10.1039/D4OB00809J
|
84 |
Esther N. Dekker, Jacob L. van Dam, Quisette P. Janssen, Marc G. Besselink, Annissa DeSilva, Deesje Doppenberg, Casper H.J. van Eijck, Naaz Nasar, Eileen M. O'Reilly, Alessandro Paniccia, Laura R. Prakash, Ching-Wei D. Tzeng, Eva M.M. Verkolf, Alice C. Wei, Amer H. Zureikat, Matthew H.G. Katz, Bas Groot Koerkamp, Rudy el Asmar, Dana Haviland, Crisanta Ilagan, Caitlin McIntyre, Sarah McIntyre, Thomas F. Stoop, Rutger T. Theijse. Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study. Journal of Clinical Oncology 2024; 42(12): 1357 doi: 10.1200/JCO.23.01311
|
85 |
Yijiao Chen, Dexiang Zhu, Miao Chen, Yuqiu Xu, Qinghai Ye, Xiaoying Wang, Pingping Xu, Qingyang Feng, Meiling Ji, Ye Wei, Jia Fan, Jianmin Xu. Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis: A Retrospective Cohort Study. Clinical Colorectal Cancer 2023; 22(4): 464 doi: 10.1016/j.clcc.2023.08.007
|
86 |
Delin Ma, Pengcheng Wei, Hengkang Liu, Jialing Hao, Zhuomiaoyu Chen, Yingming Chu, Zuyin Li, Wenzai Shi, Zhigao Yuan, Qian Cheng, Jie Gao, Jiye Zhu, Zhao Li. Multi-omics-driven discovery of invasive patterns and treatment strategies in CA19-9 positive intrahepatic cholangiocarcinoma. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05854-9
|
87 |
Anil Aysal, Ozgul Sagol. Biomarkers in Carcinoma of Unknown Primary. 2022; : 201 doi: 10.1007/978-3-030-84432-5_8
|
88 |
Jin-Lei Wang, Xiang Li, Jia-Ru Fan, Jia-Ping Yan, Ze-Mao Gong, Yue Zhao, Dong-Mei Wang, Li Ma, Na Ma, Diao-Mei Guo, Lian-Sheng Ma. Integrity of the editing and publishing process is the basis for improving an academic journal’s Impact Factor. World Journal of Gastroenterology 2022; 28(43): 6168-6202 doi: 10.3748/wjg.v28.i43.6168
|
89 |
Xiaoguang Dong, Boyang Xiao, Hieu Vu, Honglu Lin, Metin Sitti. Millimeter-scale soft capsules for sampling liquids in fluid-filled confined spaces. Science Advances 2024; 10(35) doi: 10.1126/sciadv.adp2758
|
90 |
Francesco Muraca, Fausto Gueths Gomes, Gustavo Marçal Schmidt Garcia Moreira, Matthias Ocker. Handbook of Cancer and Immunology. 2024; : 1 doi: 10.1007/978-3-030-80962-1_405-1
|
91 |
Hui Li, Rongqiang Liu, Haizhou Qiu, Yang Huang, Wenbin Liu, Jiaxin Li, Hong Wu, Genshu Wang, Dewei Li. Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.829407
|
92 |
Rashmi Bangarh, Chainika Khatana, Simranjeet Kaur, Anchita Sharma, Ankur Kaushal, Samarjeet Singh Siwal, Hardeep Singh Tuli, Kuldeep Dhama, Vijay Kumar Thakur, Reena V. Saini, Adesh K. Saini. Aberrant protein glycosylation: Implications on diagnosis and Immunotherapy. Biotechnology Advances 2023; 66: 108149 doi: 10.1016/j.biotechadv.2023.108149
|
93 |
Suparat Cotchim, Supatinee Kongkaew, Panote Thavarungkul, Proespichaya Kanatharana, Warakorn Limbut. A dual-electrode label-free immunosensor based on in situ prepared Au–MoO3-Chi/porous graphene nanoparticles for point-of-care detection of cholangiocarcinoma. Talanta 2024; 272: 125755 doi: 10.1016/j.talanta.2024.125755
|
94 |
Imteyaz Ahmad Khan, Nidhi Singh, Deepak Gunjan, Baibaswata Nayak, Nihar Ranjan Dash, Sujoy Pal, Neelam Lohani, Rajni Yadav, Surabhi Gupta, Anoop Saraya. Serum miR‐215‐5p, miR‐192‐5p and miR-378a-5p as novel diagnostic biomarkers for periampullary adenocarcinoma. Pathology - Research and Practice 2024; 260: 155417 doi: 10.1016/j.prp.2024.155417
|
95 |
Yanjun Sun, Junfeng Gong, Zhuang Li, Lin Han, Dengqun Sun. Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapy. Postgraduate Medicine 2024; 136(3): 278 doi: 10.1080/00325481.2024.2345585
|
96 |
Tsinrong Lee, Thomas Zheng Jie Teng, Vishal G Shelat. Choledochoscopy: An update. World Journal of Gastrointestinal Endoscopy 2021; 13(12): 571-592 doi: 10.4253/wjge.v13.i12.571
|
97 |
Yinjiao Wang, Yu Lou, Lang Chen, Xin Yang, Aihong Cao, Peng Du. A hepatic sparganosis misdiagnosed as intrahepatic mass-forming cholangiocarcinoma: a case report and literature review. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1391256
|
98 |
Faisal Saud Dar, Zaigham Abbas, Irfan Ahmed, Muhammad Atique, Usman Iqbal Aujla, Muhammad Azeemuddin, Zeba Aziz, Abu Bakar Hafeez Bhatti, Tariq Ali Bangash, Amna Subhan Butt, Osama Tariq Butt, Abdul Wahab Dogar, Javed Iqbal Farooqi, Faisal Hanif, Jahanzaib Haider, Siraj Haider, Syed Mujahid Hassan, Adnan Abdul Jabbar, Aman Nawaz Khan, Muhammad Shoaib Khan, Muhammad Yasir Khan, Amer Latif, Nasir Hassan Luck, Ahmad Karim Malik, Kamran Rashid, Sohail Rashid, Mohammad Salih, Abdullah Saeed, Amjad Salamat, Ghias-un-Nabi Tayyab, Aasim Yusuf, Haseeb Haider Zia, Ammara Naveed. National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma. World Journal of Gastroenterology 2024; 30(9): 1018-1042 doi: 10.3748/wjg.v30.i9.1018
|
99 |
Erkan Topkan, Ugur Selek, Berrin Pehlivan, Ahmet Kucuk, Veysel Haksoyler, Nulifer Kilic Durankus, Duygu Sezen, Yasemin Bolukbasi. The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy. Journal of Inflammation Research 2021; : 4433 doi: 10.2147/JIR.S329611
|
100 |
José Donizeti de MEIRA-JÚNIOR, Thiago Nogueira COSTA, Andre Luis MONTAGNINI, Sergio Carlos NAHAS, Jose JUKEMURA. ELEVATED CA 19-9 IN AN ASYMPTOMATIC PATIENT: WHAT DOES IT MEAN?. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2022; 35 doi: 10.1590/0102-672020220002e1687
|
101 |
Di Wang, Valeriia Kuzyk, Katarina Madunić, Tao Zhang, Oleg A. Mayboroda, Manfred Wuhrer, Guinevere S. M. Lageveen-Kammeijer. In-Depth Analysis of the N-Glycome of Colorectal Cancer Cell Lines. International Journal of Molecular Sciences 2023; 24(5): 4842 doi: 10.3390/ijms24054842
|
102 |
Marcel Kremser, Nathalie Weiss, Anne Kaufmann-Stoeck, Laura Vierbaum, Arthur Schmitz, Ingo Schellenberg, Stefan Holdenrieder. Longitudinal evaluation of external quality assessment results for CA 15-3, CA 19-9, and CA 125. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1401619
|
103 |
Daniel Vasile Balaban, Flavius Stefan Marin, George Manucu, Andreea Zoican, Marina Ciochina, Victor Mina, Cristina Patoni, Catalina Vladut, Sandica Bucurica, Raluca Simona Costache, Florentina Ionita-Radu, Mariana Jinga. Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer. World Journal of Clinical Oncology 2022; 13(7): 630-640 doi: 10.5306/wjco.v13.i7.630
|
104 |
Chanza F. Shaikh, Laura Alaimo, Zorays Moazzam, Yutaka Endo, Henrique A. Lima, Zaiba Dawood, Muhammad M. Munir, Timothy M. Pawlik. Predicting overall and recurrence‐free survival in patients with intrahepatic cholangiocarcinoma using the MEGNA score: A multi‐institutional analysis. Journal of Surgical Oncology 2023; 127(1): 73 doi: 10.1002/jso.27098
|
105 |
Taku Yamada, Taichi Minami, Masayo Yamada, Yasuo Terauchi. Proposed carbohydrate antigen 19-9 (CA19-9) cut-off values for the detection of pancreatic cancer in patients with poorly controlled diabetes: a real-world study. Endocrine Journal 2023; 70(11): 1069 doi: 10.1507/endocrj.EJ23-0186
|
106 |
Ashwini S. Sanji, Manasa J., Maruti J. Gurav, Surinder K. Batra, Vishwanath B. Chachadi. Cancer snap-shots: Biochemistry and glycopathology of O-glycans: A review. International Journal of Biological Macromolecules 2024; 260: 129318 doi: 10.1016/j.ijbiomac.2024.129318
|
107 |
Jia Jia Wee, Charles K F Vu, Cristine Szu Lyn Ding, Vishal G Shelat. Intrapancreatic accessory spleen with an epidermoid cyst: a malignant mimicry. BMJ Case Reports 2022; 15(2): e247737 doi: 10.1136/bcr-2021-247737
|
108 |
Kai Siang Chan, Vishal Shelat. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases. 2022; : 509 doi: 10.1007/978-981-19-0063-1_66
|
109 |
Zorays Moazzam, Laura Alaimo, Yutaka Endo, Henrique A Lima, Andrea Ruzzenente, Alfredo Guglielmi, Luca Aldrighetti, Matthew Weiss, Todd W Bauer, Sorin Alexandrescu, George A Poultsides, Shishir K Maithel, Hugo P Marques, Guillaume Martel, Carlo Pulitano, Feng Shen, François Cauchy, Bas Groot Koerkamp, Itaru Endo, Jordan Cloyd, Aslam Ejaz, Timothy M Pawlik. Combined Tumor Burden Score and Carbohydrate Antigen 19-9 Grading System to Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma. Journal of the American College of Surgeons 2023; 236(4): 804 doi: 10.1097/XCS.0000000000000557
|
110 |
Xinyu Cheng, Jianguo Xia, Qi Xu, Huawei Gui. The value of color Doppler ultrasonography combined with serum tumor markers in differential diagnosis of gastric stromal tumor and gastric cancer. Open Medicine 2023; 18(1) doi: 10.1515/med-2023-0805
|
111 |
Iris J. M. Levink, Sanne C. Jaarsma, Brechtje D. M. Koopmann, Priscilla A. van Riet, Kasper A. Overbeek, Jihane Meziani, Marloes L. J. A. Sprij, Riccardo Casadei, Carlo Ingaldi, Marcin Polkowski, Megan M. L. Engels, Laurens A. van der Waaij, Silvia Carrara, Elizabeth Pando, Marlies Vornhülz, Pieter Honkoop, Erik J. Schoon, Johanna Laukkarinen, Jilling F. Bergmann, Gemma Rossi, Frederike G. I. van Vilsteren, Anne‐Marie van Berkel, Trevor Tabone, Matthijs P. Schwartz, Adriaan C. I. T. L. Tan, Jeanin E. van Hooft, Rutger Quispel, Ellert van Soest, Laszlo Czacko, Marco J. Bruno, Djuna L. Cahen. The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program. United European Gastroenterology Journal 2023; 11(7): 601 doi: 10.1002/ueg2.12422
|
112 |
Francesca Pezzuto, Francesco Izzo, Pasquale De Luca, Elio Biffali, Luigi Buonaguro, Fabiana Tatangelo, Franco Maria Buonaguro, Maria Lina Tornesello. Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma. Cancers 2021; 13(15): 3771 doi: 10.3390/cancers13153771
|
113 |
Lan Wang, Ming Li, Tiantian Dong, Yuanyuan Li, Ci Yin, Fang Nie. Pancreatic Ductal Adenocarcinoma: The Characteristics of Contrast-Enhanced Ultrasound Are Correlated with the Hypoxic Microenvironment. Diagnostics 2023; 13(20): 3270 doi: 10.3390/diagnostics13203270
|
114 |
Sowbharnika Arivazhagan, Deepti Kantamani, Natalee E Tanner, Madappa N Kundranda, M. Patrick Stagg. Infection Masquerading as Recurrence of Pancreatic Ductal Adenocarcinoma: A Cautionary Tale. Cureus 2021; doi: 10.7759/cureus.17010
|
115 |
Wenwen Wang, Guo Chen, Wenli Zhang, Xihua Zhang, Manli Huang, Chen Li, Ling Wang, Zifan Lu, Jielai Xia. The crucial prognostic signaling pathways of pancreatic ductal adenocarcinoma were identified by single-cell and bulk RNA sequencing data. Human Genetics 2024; 143(9-10): 1109 doi: 10.1007/s00439-024-02663-4
|
116 |
Nida Ansari, Sacide S Ozgur, Damian Besada, Noor Bittar, Gabriel Melki, Kanthi Badipatla, Derick Christian, Yana Cavanagh. Carbohydrate Antigen (CA 19-9) Surge: Unraveling the Enigma of Elevated Levels in the Setting of Benign Etiologies. Cureus 2024; doi: 10.7759/cureus.57469
|
117 |
Haoming Tang, Yi Xin Li, Jun Jie Lian, Hsin-Yueh Ng, Samuel Sherng Young Wang. Personalized treatment using predictive biomarkers in solid organ malignancies: A review. Tumori Journal 2024; 110(5): 386 doi: 10.1177/03008916241261484
|
118 |
Hedyeh Rahmani, Samira Mansouri Majd, Abdollah Salimi, Foad Ghasemi. Ultrasensitive immunosensor for monitoring of CA 19-9 pancreatic cancer marker using electrolyte-gated TiS3 nanoribbons field-effect transistor. Talanta 2023; 257: 124336 doi: 10.1016/j.talanta.2023.124336
|
119 |
Makoto Takeda, Yoshinori Onuki, Kosuke Oishi, Osamu Kubota, Takashi Uchiyama, Yoshifumi Arai, Hiroya Takeuchi. Giant Mucinous Carcinoma Originating from the Appendix: A Case Report. International Surgery 2021; 105(1-3): 697 doi: 10.9738/INTSURG-D-20-00044.1
|
120 |
Barbara Link, Adriana Torres Crigna, Michael Hölzel, Frank A. Giordano, Olga Golubnitschaja. Abscopal Effects in Metastatic Cancer: Is a Predictive Approach Possible to Improve Individual Outcomes?. Journal of Clinical Medicine 2021; 10(21): 5124 doi: 10.3390/jcm10215124
|
121 |
Patrick Michl, Matthias Löhr, John P. Neoptolemos, Gabriele Capurso, Vinciane Rebours, Nuria Malats, Mathilde Ollivier, Luigi Ricciardiello. UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better. United European Gastroenterology Journal 2021; 9(7): 860 doi: 10.1002/ueg2.12123
|
122 |
Taskeen Ebrahim, Willem Perold, Anna-Mart Engelbrecht. A Capacitive Biosensor for the Early Detection of Pancreatic Cancer Using Carbohydrate Antigen 19-9. The 9th International Electronic Conference on Sensors and Applications 2022; : 74 doi: 10.3390/ecsa-9-13322
|
123 |
Shahnam Valizadeh Shahbazlou, Somayeh Vandghanooni, Bahareh Dabirmanesh, Morteza Eskandani, Sadegh Hasannia. Recent advances in surface plasmon resonance for the detection of ovarian cancer biomarkers: a thorough review. Microchimica Acta 2024; 191(11) doi: 10.1007/s00604-024-06740-3
|
124 |
Ruth González-Gómez, Roberto A. Pazo-Cid, Luis Sarría, Miguel Ángel Morcillo, Alberto J. Schuhmacher. Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography. Journal of Clinical Medicine 2021; 10(6): 1151 doi: 10.3390/jcm10061151
|